NO984342L - Rensing av plasmid-DNA av farmas°ytisk kvalitet - Google Patents

Rensing av plasmid-DNA av farmas°ytisk kvalitet

Info

Publication number
NO984342L
NO984342L NO984342A NO984342A NO984342L NO 984342 L NO984342 L NO 984342L NO 984342 A NO984342 A NO 984342A NO 984342 A NO984342 A NO 984342A NO 984342 L NO984342 L NO 984342L
Authority
NO
Norway
Prior art keywords
purification
plasmid dna
pharmaceutical grade
grade plasmid
pharmaceutical
Prior art date
Application number
NO984342A
Other languages
English (en)
Norwegian (no)
Other versions
NO984342D0 (no
Inventor
Pierre Wils
Monique Ollivier
Original Assignee
Rh Ne Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rh Ne Poulenc Rorer Sa filed Critical Rh Ne Poulenc Rorer Sa
Publication of NO984342D0 publication Critical patent/NO984342D0/no
Publication of NO984342L publication Critical patent/NO984342L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO984342A 1996-03-21 1998-09-18 Rensing av plasmid-DNA av farmas°ytisk kvalitet NO984342L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9603519A FR2746412B1 (fr) 1996-03-21 1996-03-21 Purification d'adn plasmidique de qualite pharmaceutique
PCT/FR1997/000472 WO1997035002A1 (fr) 1996-03-21 1997-03-17 Purification d'adn plasmidique de qualite pharmaceutique

Publications (2)

Publication Number Publication Date
NO984342D0 NO984342D0 (no) 1998-09-18
NO984342L true NO984342L (no) 1998-09-18

Family

ID=9490391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984342A NO984342L (no) 1996-03-21 1998-09-18 Rensing av plasmid-DNA av farmas°ytisk kvalitet

Country Status (15)

Country Link
US (1) US6730781B1 (cs)
EP (1) EP0902835A1 (cs)
JP (1) JP2000506736A (cs)
KR (1) KR100502116B1 (cs)
AU (1) AU730755B2 (cs)
BR (1) BR9708227A (cs)
CA (1) CA2249465A1 (cs)
CZ (1) CZ295587B6 (cs)
FR (1) FR2746412B1 (cs)
HU (1) HU225426B1 (cs)
IL (1) IL126268A0 (cs)
NO (1) NO984342L (cs)
SK (1) SK129198A3 (cs)
WO (1) WO1997035002A1 (cs)
ZA (1) ZA972462B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US6214586B1 (en) * 1997-12-08 2001-04-10 Genzyme Corporation Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA
CZ303086B6 (cs) * 2000-05-26 2012-03-28 Aventis Pharma S.A. Zpusob purifikace dvojretezcové DNA užitím imobilizovaného oligonukleotidu
FR2822476B1 (fr) * 2001-03-23 2004-04-02 Aventis Pharma Sa Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice
WO2002077274A2 (fr) * 2001-03-23 2002-10-03 Gencell S.A. Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice.
EP1554398A4 (en) 2002-09-13 2005-12-14 Valentis Inc DEVICE AND METHOD FOR THE CLEANING OF NUCLEAR SULFUR IN THE PREPARATIVE SCALE
EP1628749B1 (en) 2003-05-30 2019-07-31 VGXI, Inc. Devices and methods for biomaterial production
EP1664277B1 (en) * 2003-09-17 2011-11-09 Aventis Pharma S.A. Method of preparation of pharmaceutically grade plasmid dna
AU2005233309B2 (en) * 2004-04-19 2011-03-31 Centelion Method for purifying plasmid DNA
EP1737945B1 (en) * 2004-04-19 2011-01-26 Aventis Pharma S.A. Method for purifying plasmid dna
AU2005280356B2 (en) 2004-08-16 2008-09-25 Clague P. Hodgson Improved strains of E. coli for plasmid DNA production
CN101443452B (zh) 2004-11-30 2013-03-27 梅瑞尔有限公司 用于细胞化学裂解的混合装置
US20120258502A1 (en) * 2011-04-08 2012-10-11 Vinod Pandiripally Method of producing recombinant plasmid dna using substantially solid growth medium
US20120283503A1 (en) * 2011-04-29 2012-11-08 The Johns Hopkins University Nanoparticle loaded stem cells and their use in mri guided hyperthermia
CN116790578B (zh) * 2023-08-22 2023-12-12 赛奥斯博生物科技(北京)有限公司 一种基于碱裂解法快速纯化质粒的生产工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2691586B2 (ja) * 1987-10-22 1997-12-17 旭光学工業株式会社 多孔質セラミックス及びその製法
JPH01135792A (ja) * 1987-11-20 1989-05-29 Mitsui Toatsu Chem Inc 核酸の分離・精製方法
CA2006008C (en) * 1988-12-20 2000-02-15 Donald J. Kessler Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
JPH08505534A (ja) * 1993-01-13 1996-06-18 森永乳業株式会社 Ｍ−ｃｓｆ２２３の製造方法
US5503816A (en) * 1993-09-27 1996-04-02 Becton Dickinson And Company Silicate compounds for DNA purification
DE59507433D1 (de) * 1994-02-07 2000-01-20 Qiagen Gmbh Verfahren zur herstellung endotoxinfreier oder an endotoxin abgereicherter nucleinsäuren und/oder oligonucleotide für die gentherapie
US5576196A (en) * 1995-01-13 1996-11-19 Vical Incorporated Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth
ATE238321T1 (de) 1996-02-06 2003-05-15 Roche Diagnostics Gmbh Verfahren zur herstellung von gereinigter nukleinsäure und deren verwendung

Also Published As

Publication number Publication date
JP2000506736A (ja) 2000-06-06
HUP9902152A3 (en) 2001-04-28
IL126268A0 (en) 1999-05-09
ZA972462B (en) 1997-09-29
HUP9902152A2 (hu) 1999-11-29
NO984342D0 (no) 1998-09-18
AU2166197A (en) 1997-10-10
CZ295587B6 (cs) 2005-08-17
BR9708227A (pt) 1999-07-27
US6730781B1 (en) 2004-05-04
CA2249465A1 (fr) 1997-09-25
KR20000064693A (ko) 2000-11-06
WO1997035002A1 (fr) 1997-09-25
EP0902835A1 (fr) 1999-03-24
FR2746412A1 (fr) 1997-09-26
CZ298498A3 (cs) 1999-01-13
AU730755B2 (en) 2001-03-15
KR100502116B1 (ko) 2005-12-20
HU225426B1 (en) 2006-11-28
FR2746412B1 (fr) 1998-06-12
SK129198A3 (en) 1999-03-12

Similar Documents

Publication Publication Date Title
NO984342L (no) Rensing av plasmid-DNA av farmas°ytisk kvalitet
EP0521108A4 (en) Site specific cleavage of single-stranded dna
NO975280D0 (no) Fremgangsmåte for rensing av plasmid i stor skala
AU3672797A (en) Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
DE69212216D1 (de) Festphase-Extraktionsreinigung von DNA
FI973055A0 (fi) Soluja yhdistelmä-DNA-adenovirusten tuottamiseksi
EP0996632A4 (en) Angiostatin fragments and method of use
EP0968223A4 (en) BIOKON JUGATION OF MACROMOLECULES
FI960469L (fi) DNA:ta sekvenssoivia entsyymejä
PT907364E (pt) Composicao farmaceutica de libertacao sustida
DE69731646D1 (de) Verabreichung von nukleinsäurepartikeln
NO986177L (no) FremgangsmÕte for fremstilling av terapeutisk DNA
AU4314099A (en) Novel method of large scale plasmid purification
EP1036159A4 (en) METHOD FOR PURIFYING PLASMID DNA AND PLASMID DNA THAT IS SUBSTANTIALLY FREE OF GENOMIC DNA
EP1012279A4 (en) MITOFUSIN GENES AND THEIR USE
AU2091400A (en) Prefabricated biological purification system
FR2753204B1 (fr) Procede de preparation d'adn plasmidique
ID17125A (id) Aksi berlanjut sediaan obat tipe satuan ganda
NO981322L (no) Farmas÷ytiske preparater for bruk ved nukleinsyretransfeksjon, og deres anvendelse
EP0939764A4 (en) MOLECULAR GENETIC CONSTRUCTION OF PASTEURELLACEAE-BASED VACCINE STRAINS
DE69827137D1 (de) Aminoethylphenoxyessigsäure-derivate und medikamente zur schmerzlinderung und förderung der entfernung von konkrementen bei urolithiasis
AU3569600A (en) Purification of biological preparations
PL349344A1 (en) Liposomic niflumic acid - new transdermal anti-inflammatory medicine
BR9706942A (pt) Método de transformação genética de árvores

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application